EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

Overexpression of the EVI1 (ecotropic viral integration site 1) oncogene has recently been implicated as a prognostic factor in breast cancer (BC), particularly in triple-negative BC (TNBC). In this study we aimed to investigate frequency and clinical relevance of EVI1 expression in newly diagnosed...

Full description

Bibliographic Details

Main Authors:	Leichsenring, Jonas (Author) , Vladimirova, Valentina (Author) , Solbach, Christine (Author) , Karn, Thomas (Author) , Ataseven, Beyhan (Author) , Sinn, Bruno Valentin (Author) , Barinoff, Jana (Author) , Müller, Volkmar (Author) , Blohmer, Jens-Uwe (Author) , Schem, Christian (Author) , Engels, Knut (Author) , Marmé, Frederik (Author) , Fisseler-Eckhoff, Annette (Author) , Fasching, Peter A. (Author) , Stickeler, Elmar (Author) , van Mackelenbergh, Marion (Author) , Denkert, Carsten (Author) , Stenzinger, Albrecht (Author) , Loibl, Sibylle (Author) , Gröschel, Stefan (Author)
Format:	Article (Journal)
Language:	English
Published:	05 October 2022
In:	BMC cancer Year: 2022, Volume: 22, Pages: 1-10
ISSN:	1471-2407
DOI:	10.1186/s12885-022-10109-1
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12885-022-10109-1
Author Notes:	Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, Jana Barinoff, Volkmar Müller, Jens-Uwe Blohmer, Christian Schem, Knut Engels, Frederik Marmé, Annette Fisseler-Eckhoff, Peter A. Fasching, Elmar Stickeler, Marion van Mackelenbergh, Carsten Denkert, Albrecht Stenzinger, Sibylle Loibl and Stefan Gröschel